Allspring Global Investments
RCUS icon

Allspring Global Investments’s Arcus Biosciences RCUS Stock Holding History

Allspring Global Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629K Buy
21,764
+723
+3% +$17.9K ﹤0.01% 1392
2026
Q1 		$460K Buy
21,041
+2,168
+11% +$46.8K ﹤0.01% 1412
2025
Q4 		$440K Buy
18,873
+1,649
+10% +$33.6K ﹤0.01% 1411
2025
Q3 		$232K Sell
17,224
-170
-1% -$1.77K ﹤0.01% 1530
2025
Q2 		$145K Sell
17,394
-1,011
-5% -$8.64K ﹤0.01% 1569
2025
Q1 		$144K Buy
18,405
+6,453
+54% +$74.8K ﹤0.01% 1679
2024
Q4 		$178K Buy
11,952
+28
+0.2% +$457 ﹤0.01% 1685
2024
Q3 		$182K Sell
11,924
-884
-7% -$13.9K ﹤0.01% 1688
2024
Q2 		$195K Sell
12,808
-132
-1% -$2.13K ﹤0.01% 1711
2024
Q1 		$244K Buy
12,940
+1,090
+9% +$18.8K ﹤0.01% 1665
2023
Q4 		$226K Buy
11,850
+2,516
+27% +$40.2K ﹤0.01% 1665
2023
Q3 		$168K Buy
9,334
+230
+3% +$4.62K ﹤0.01% 1810
2023
Q2 		$185K Sell
9,104
-6,968
-43% -$133K ﹤0.01% 1833
2023
Q1 		$293K Buy
16,072
+3,703
+30% +$70.8K ﹤0.01% 1726
2022
Q4 		$256K Sell
12,369
-828
-6% -$22.8K ﹤0.01% 1769
2022
Q3 		$345K Buy
13,197
+3,315
+34% +$87.7K ﹤0.01% 1665
2022
Q2 		$250K Sell
9,882
-9,668
-49% -$237K ﹤0.01% 1753
2022
Q1 		$616K Sell
19,550
-700
-3% -$23.5K ﹤0.01% 2133
2021
Q4 		$819K Buy
+20,250
New +$786K ﹤0.01% 2055

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Allspring Global Investments's RCUS Position: Q2 2026 in Review

Allspring Global Investments increased its Arcus Biosciences (RCUS) stake by 3.4% in Q2 2026, buying an estimated $17.9K and bringing the position to 21,764 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Allspring Global Investments first reported a position in RCUS in Q4 2021 and has held it in 19 quarters since. The position peaked at $819K in Q4 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Allspring Global Investments held 21,764 shares of Arcus Biosciences worth $629K as of Q2 2026.
  • Allspring Global Investments bought 723 Arcus Biosciences shares in Q2 2026, an estimated $17.9K.
  • Arcus Biosciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1392 holding.
  • Allspring Global Investments first reported a position in Arcus Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Arcus Biosciences position peaked at $819K in Q4 2021.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.